Cingulate CING
NASDAQ CING
$5.55 +0.22 (+4.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cingulate (CING) Current Assets (2021 - 2026)

Cingulate's (CING) quarterly Current Assets came in at $12.0 million in Q4 2025, down 5.15% YoY from $12.7 million in Q4 2024, and up 61.55% on a QoQ basis from $7.4 million in Q3 2025.

Cingulate (CING) Current Assets (2021 - 2026) Analysis & Trends

Cingulate (CING) has 5 years of Current Assets data on file, last reported at $12.0 million in Q4 2025.

  • Quarterly Current Assets fell 5.15% year-over-year to $12.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.0 million (down 5.15% YoY) and the FY2025 annual result came in at $12.0 million, down 5.15% from the prior year.
  • Current Assets climbed to $12.0 million in Q4 2025, from $7.4 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $18.9 million in Q4 2021 to a low of $578594.0 in Q4 2023.
  • A 5-year average of $8.2 million and a median of $9.0 million in 2022 frame the typical range for Current Assets.
  • Annual changes were most pronounced in 2023 — Current Assets plunged 92.65% — and 2024, when it surged 2088.2%.
  • Tracing CING's Current Assets over 5 years: stood at $18.9 million in 2021, then sank by 58.32% to $7.9 million in 2022, then sank by 92.65% to $578594.0 in 2023, then surged by 2088.2% to $12.7 million in 2024, then fell by 5.15% to $12.0 million in 2025.
  • The last three Current Assets figures came in at $12.0 million (Q4 2025), $7.4 million (Q3 2025), and $10.5 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 12.54 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 18.45 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 8.07 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.82 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 7.22 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 4.62 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 18.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.63 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 1.76 Bn
10 Cingulate 72.85 Mn 72.85 Mn - 30.21 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 30.21 Mn
Dec 31, 2025 12.01 Mn
Sep 30, 2025 7.43 Mn
Mar 31, 2025 10.50 Mn
Dec 31, 2024 12.66 Mn
Sep 30, 2024 11.34 Mn
Jun 30, 2024 2.52 Mn
Mar 31, 2024 2.73 Mn
Dec 31, 2023 578,594.00
Sep 30, 2023 2.90 Mn
Jun 30, 2023 2.04 Mn
Mar 31, 2023 3.75 Mn
Dec 31, 2022 7.87 Mn
Sep 30, 2022 11.83 Mn
Jun 30, 2022 10.10 Mn
Mar 31, 2022 14.57 Mn
Dec 31, 2021 18.88 Mn